Clinical study of recombinant anti-tumor and anti-virus protein injection compared with placebo in metastatic colorectal cancer after failure of second-line and more than second-line treatment

doi:10.3969/j.issn.1009-0460.2013.08.001

Home>Articles>Clinical study of recombinant anti-tumor and anti-virus protein injection compared with placebo in metastatic colorectal cancer after failure of second-line and more than second-line treatment

DOI: 10.3969/j.issn.1009-0460.2013.08.001

Clinical study of recombinant anti-tumor and anti-virus protein injection compared with placebo in metastatic colorectal cancer after failure of second-line and more than second-line treatment

Keywords：Metastatic colorectal cancerAnti-tumor and anti-virus proteinNovaferonImmunotherapyFlow cytometry

Publication Date：2013-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 673-678 )

Chinese Clinical Oncology

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2013,18(8)